More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura. - Vazquez-Mellado A; Pequeño-Luévano M; Cantu-Rodriguez OG; Villarreal-Martínez L; Jaime-Pérez JC; Gomez-De-Leon A; De La Garza-Salazar F; Gonzalez-Llano O; Colunga-Pedraza P; Sotomayor-Duque G; Gomez-Almaguer D (Hematology (Amsterdam, Netherlands), 2016)